Table 1 Demographic, anthropometry and clinical characteristics
From: Assessing the feasibility of injectable growth-promoting therapy in Crohn’s disease
Total n = 48 (80%) | |
|---|---|
Age/year (range) | 14.3 (7.0, 17.7) |
Sex (M), n (%) | 35 (73) |
HtSDS (range) | −1.2 (−3.01, 0.89) |
MPHSDS (range) | −0.59 (−3.14, 1.4) |
Treated for growth problem, n (%) | 4 (8) |
Family history of CD, n (%) | 8 (17) |